BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30211931)

  • 1. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 2. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
    Serruys PW; Katagiri Y; Sotomi Y; Zeng Y; Chevalier B; van der Schaaf RJ; Baumbach A; Smits P; van Mieghem NM; Bartorelli A; Barragan P; Gershlick A; Kornowski R; Macaya C; Ormiston J; Hill J; Lang IM; Egred M; Fajadet J; Lesiak M; Windecker S; Byrne RA; Räber L; van Geuns RJ; Mintz GS; Onuma Y
    J Am Coll Cardiol; 2017 Jul; 70(1):60-74. PubMed ID: 28662808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
    Opolski MP; Kepka C; Wojakowski W; Witkowski A
    Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 7. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 8. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
    Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
    Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.
    Hemetsberger R; Abdelghani M; Mankerious N; Allali A; Toelg R; Gori T; Achenbach S; Riemer T; Mehilli J; Nef HM; Naber C; Wöhrle J; Zahn R; Kastner J; Schmermund A; Hamm C; Münzel T; Richardt G;
    Coron Artery Dis; 2020 Nov; 31(7):578-585. PubMed ID: 32271247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
    Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 13. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
    Diletti R; Farooq V; Girasis C; Bourantas C; Onuma Y; Heo JH; Gogas BD; van Geuns RJ; Regar E; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn RJ; Smits P; Koolen J; Meredith I; Li X; Miquel-Hebert K; Veldhof S; Garcia-Garcia HM; Ormiston JA; Serruys PW
    Heart; 2013 Jan; 99(2):98-105. PubMed ID: 23118346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy.
    Ribichini F; Scarsini R; Zanetti C; Pesarini G
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1270-1272. PubMed ID: 28579240
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Acute Recoil Following Bioresorbable Scaffold Implantation in Fibrocalcific Lesion Detected by Optical Frequency-Domain Imaging.
    Kawamoto H; Ruparelia N; Tanaka A; Latib A; Colombo A
    J Invasive Cardiol; 2016 Mar; 28(3):E34-6. PubMed ID: 26945257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary calcification as a mechanism of plaque/media shrinkage in vessels treated with bioresorbable vascular scaffold: A multimodality intracoronary imaging study.
    Zeng Y; Cavalcante R; Collet C; Tenekecioglu E; Sotomi Y; Miyazaki Y; Katagiri Y; Asano T; Abdelghani M; Nie S; Bourantas CV; Bruining N; Onuma Y; Serruys PW
    Atherosclerosis; 2018 Feb; 269():6-13. PubMed ID: 29247976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zero-Contrast Optical Coherence Tomography- and Physiology-Guided Percutaneous Coronary Intervention for Severely Calcified Lesion.
    Asakura K; Minami Y; Shimohama T; Ako J
    Circ J; 2019 Oct; 83(11):2326. PubMed ID: 31142686
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary artery perforation and acute scaffold thrombosis after bioresorbable vascular scaffold implantation for a calcified lesion.
    Lee WC; Fang HY; Wu CJ
    Int J Cardiol; 2016 Nov; 222():620-621. PubMed ID: 27517650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.